Edition:
United Kingdom

Abeona Therapeutics Inc (ABEO.OQ)

ABEO.OQ on NASDAQ Stock Exchange Capital Market

7.34USD
9:00pm BST
Change (% chg)

$-0.10 (-1.34%)
Prev Close
$7.44
Open
$7.41
Day's High
$7.48
Day's Low
$7.20
Volume
70,957
Avg. Vol
116,269
52-wk High
$19.15
52-wk Low
$6.28

About

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin... (more)

Overall

Beta: 1.91
Market Cap(Mil.): $365.77
Shares Outstanding(Mil.): 49.16
Dividend: --
Yield (%): --

Financials

  ABEO.OQ Industry Sector
P/E (TTM): -- 101.85 55.51
EPS (TTM): -1.36 -- --
ROI: -41.22 7.41 11.59
ROE: -45.09 7.88 16.33

Earnings vs. Estimates